186 related articles for article (PubMed ID: 27096202)
1. Design and Evaluation of a Multi-Epitope Peptide of Human Metapneumovirus.
Li X; Guo L; Kong M; Su X; Yang D; Zou M; Liu Y; Lu L
Intervirology; 2015; 58(6):403-12. PubMed ID: 27096202
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant effect of the human metapneumovirus (HMPV) matrix protein in HMPV subunit vaccines.
Aerts L; Rhéaume C; Carbonneau J; Lavigne S; Couture C; Hamelin MÈ; Boivin G
J Gen Virol; 2015 Apr; 96(Pt 4):767-774. PubMed ID: 25519171
[TBL] [Abstract][Full Text] [Related]
3. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
4. Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein.
Huang J; Chopra P; Liu L; Nagy T; Murray J; Tripp RA; Boons GJ; Mousa JJ
J Virol; 2021 Aug; 95(18):e0059321. PubMed ID: 34160259
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.
Herd KA; Mahalingam S; Mackay IM; Nissen M; Sloots TP; Tindle RW
J Virol; 2006 Feb; 80(4):2034-44. PubMed ID: 16439559
[TBL] [Abstract][Full Text] [Related]
6. Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response.
Wang F; Feng X; Zheng Q; Hou H; Cao R; Zhou B; Liu Q; Liu X; Pang R; Zhao J; Deng W; Chen P
Virol J; 2012 Sep; 9():204. PubMed ID: 22985466
[TBL] [Abstract][Full Text] [Related]
7. A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus
Bar-Peled Y; Diaz D; Pena-Briseno A; Murray J; Huang J; Tripp RA; Mousa JJ
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292250
[TBL] [Abstract][Full Text] [Related]
8. Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice.
Lévy C; Aerts L; Hamelin MÈ; Granier C; Szécsi J; Lavillette D; Boivin G; Cosset FL
Vaccine; 2013 Jun; 31(25):2778-85. PubMed ID: 23583815
[TBL] [Abstract][Full Text] [Related]
9. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a Mixture of Nucleoprotein from Human Metapneumovirus and AbISCO-100 Adjuvant Reduces Viral Infection in Mice Model.
Diaz-Dinamarca DA; Ibañez FJ; Soto DA; Soto JA; Cespedes PF; Muena NA; Garate DS; Kalergis AM; Vasquez AE
Viral Immunol; 2018 May; 31(4):306-314. PubMed ID: 29373084
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB/c mice.
Wei JC; Huang YZ; Zhong DK; Kang L; Ishag H; Mao X; Cao RB; Zhou B; Chen PY
Biochem Biophys Res Commun; 2010 Jun; 396(4):787-92. PubMed ID: 20457131
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a recombinant bacillus Calmette-Guerin strain confers protective Th1 immunity against the human metapneumovirus.
Palavecino CE; Céspedes PF; Gómez RS; Kalergis AM; Bueno SM
J Immunol; 2014 Jan; 192(1):214-23. PubMed ID: 24319265
[TBL] [Abstract][Full Text] [Related]
13. Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.
Alvarez R; Harrod KS; Shieh WJ; Zaki S; Tripp RA
J Virol; 2004 Dec; 78(24):14003-11. PubMed ID: 15564507
[TBL] [Abstract][Full Text] [Related]
14. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
[TBL] [Abstract][Full Text] [Related]
15. Generation of recombinant metapneumovirus nucleocapsid protein as nucleocapsid-like particles and development of virus-specific monoclonal antibodies.
Petraitytė-Burneikienė R; Nalivaiko K; Lasickienė R; Firantienė R; Emužytė R; Sasnauskas K; Zvirblienė A
Virus Res; 2011 Nov; 161(2):131-9. PubMed ID: 21827798
[TBL] [Abstract][Full Text] [Related]
16. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
[TBL] [Abstract][Full Text] [Related]
17. Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus.
Melendi GA; Zavala F; Buchholz UJ; Boivin G; Collins PL; Kleeberger SR; Polack FP
J Virol; 2007 Oct; 81(20):11461-7. PubMed ID: 17670840
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice.
Ma F; Chen A; Yao L; Gao H; Zhang Q; Hou W; Zheng L
Virus Res; 2023 Oct; 336():199215. PubMed ID: 37657510
[TBL] [Abstract][Full Text] [Related]
19. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
Uppada SB; Bhat AA; Sah A; Donthamshetty RN
Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
[TBL] [Abstract][Full Text] [Related]
20. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
